Edwards Lifesciences
1,243 hedge funds and large institutions have $42.4B invested in Edwards Lifesciences in 2022 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 445 increasing their positions, 458 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 1,269 → 1,243 (-26)
12% less capital invested
Capital invested by funds: $48.2B → $42.4B (-$5.8B)
18% less funds holding in top 10
Funds holding in top 10: 22 → 18 (-4)
Holders
1,243
Holding in Top 10
18
Calls
$189M
Puts
$130M
Top Buyers
| 1 | +$660M | |
| 2 | +$218M | |
| 3 | +$212M | |
| 4 |
Amundi
Paris,
France
|
+$111M |
| 5 |
Holocene Advisors
New York
|
+$93.9M |
Top Sellers
| 1 | -$321M | |
| 2 | -$216M | |
| 3 | -$188M | |
| 4 |
Bank of New York Mellon
New York
|
-$131M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$126M |